Provectus Biopharmaceuticals Inc (PVCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2005 | |
| Assets | |
| Current Assets | |
| Cash & Cash Equivalents | 6,870 |
| Other current assets | 70 |
| TOTAL | $6,940 |
| Non-Current Assets | |
| PPE Net | 10 |
| Other Non-Current Assets | 10,340 |
| TOTAL | $10,350 |
| Total Assets | $17,310 |
| Liabilities | |
| Current Liabilities | |
| Accounts payable and accrued liabilities | 90 |
| Accrued Expenses | 1,960 |
| TOTAL | $2,600 |
| Non-Current Liabilities | |
| Other Non-Current Liabilities | 320 |
| TOTAL | $320 |
| Total Liabilities | $2,930 |
| Shareholders' Equity | |
| Common Shares | 20 |
| Retained earnings | -26,330 |
| Other shareholders' equity | 10 |
| TOTAL | $14,380 |
| Total Liabilities And Equity | $17,310 |